Search on website
Filters
Show more
idea-icon

Summary of the Day

Electroconvulsive Therapy Anesthetic Considerations

Read Summary chevron-left-black
note-icon

Question of the Day

A 23-year-old, otherwise healthy woman with recurrent headaches presents for computed tomography angiography of the head. After the administration of hyperosmolar contrast, she develops rash, wheezing, and nausea. Which of the following physiologic mechanisms is MOST likely involved in this reaction?

Question of the Day
A 23-year-old, otherwise healthy woman with recurrent headaches presents for computed tomography angiography of the head. After the administration of hyperosmolar contrast, she develops rash, wheezing, and nausea. Which of the following physiologic mechanisms is MOST likely involved in this reaction?
Your Answer
Correct Answer

Explanation

Hypersensitivity reactions to contrast dye are quite common ranging from 4-12% with the use of ionic (hyperosmolar) contrast dye and 1-3% with nonionic contrast. Most reactions to hyperosmolar contrast dye are nonallergic or anaphylactoid (Type II) reactions. In fact, it is rare to have true anaphylactic (Type I) reactions to iodine mediated by antigen-IgE cross-linking with subsequent histamine release. Anaphylactoid reactions have a complex mechanism involving complement activation, direct degranulation of mast cells and basophils, and modulation of enzymes and proteolytic cascades but are not IgE-mediated. Clinically, anaphylactic and anaphylactoid reactions are indistinguishable causing urticaria, nausea, vomiting, and wheezing. Hypersensitivity reactions to contrast dye can often be prevented or lessened with the use of prophylactic corticosteroids and antihistamine medications. Type III or immune complex mediated reactions are seen in autoimmune syndromes including rheumatoid arthritis and systemic lupus erythematosus. Type IV or delayed-type hypersensitivity reactions involve the activation of T-cells and an example is the delayed hypersensitivity reaction to poison ivy.

OA Series: November 2024

vodcast-icon-blue-2 Vodcast

play-icon-2 05:08

SPPM Visual Pearls

Spotlight on Ketamine: From Pain Relief to Public Concern

Deepa Kattail, MD MHS FAAP, The Hospital for Sick Children, Toronto, ON, Canada

podcast-icon-green Podcast
podcast-placeholder

play-icon-2 35:32

OA Global Health Equity Ask the Expert

Health Equity Curriculum for Anesthesia Residents

Samuel Percy, MD, Children's Hospital Colorado, Aurora, CO